JPS5948480A - 麦角アルカロイド - Google Patents

麦角アルカロイド

Info

Publication number
JPS5948480A
JPS5948480A JP58144843A JP14484383A JPS5948480A JP S5948480 A JPS5948480 A JP S5948480A JP 58144843 A JP58144843 A JP 58144843A JP 14484383 A JP14484383 A JP 14484383A JP S5948480 A JPS5948480 A JP S5948480A
Authority
JP
Japan
Prior art keywords
compound
acid addition
alkyl
addition salt
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58144843A
Other languages
English (en)
Japanese (ja)
Inventor
ペ−タ−・グル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5948480A publication Critical patent/JPS5948480A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP58144843A 1982-08-09 1983-08-08 麦角アルカロイド Pending JPS5948480A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4772/82 1982-08-09
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.

Publications (1)

Publication Number Publication Date
JPS5948480A true JPS5948480A (ja) 1984-03-19

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58144843A Pending JPS5948480A (ja) 1982-08-09 1983-08-08 麦角アルカロイド

Country Status (23)

Country Link
JP (1) JPS5948480A (da)
AT (1) AT383125B (da)
AU (1) AU563736B2 (da)
BE (1) BE897473A (da)
CA (1) CA1215972A (da)
CH (1) CH649998A5 (da)
DE (1) DE3327705A1 (da)
DK (1) DK361983A (da)
ES (1) ES8502992A1 (da)
FI (1) FI73679C (da)
FR (1) FR2531433B1 (da)
GB (1) GB2125041B (da)
GR (1) GR78923B (da)
HU (1) HU187600B (da)
IL (1) IL69450A (da)
IT (1) IT1168961B (da)
MY (1) MY8700166A (da)
NL (1) NL8302776A (da)
NZ (1) NZ205181A (da)
PH (1) PH20385A (da)
PT (1) PT77168B (da)
SE (1) SE8304315L (da)
ZA (1) ZA835850B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
BE897473A (fr) 1984-02-06
DE3327705A1 (de) 1984-02-09
DK361983A (da) 1984-02-10
DK361983D0 (da) 1983-08-08
AU1767283A (en) 1984-02-16
FI73679B (fi) 1987-07-31
IT8322490A0 (it) 1983-08-09
ZA835850B (en) 1985-03-27
SE8304315L (sv) 1984-02-10
CH649998A5 (de) 1985-06-28
IT1168961B (it) 1987-05-20
IL69450A0 (en) 1983-11-30
HU187600B (en) 1986-01-28
PT77168A (en) 1983-09-01
FI832789A (fi) 1984-02-10
MY8700166A (en) 1987-12-31
PH20385A (en) 1986-12-08
ES524815A0 (es) 1985-02-01
ATA286383A (de) 1986-10-15
ES8502992A1 (es) 1985-02-01
SE8304315D0 (sv) 1983-08-08
CA1215972A (en) 1986-12-30
NZ205181A (en) 1986-07-11
FR2531433B1 (fr) 1985-10-18
FI832789A0 (fi) 1983-08-02
GB2125041B (en) 1986-04-23
FI73679C (fi) 1987-11-09
GR78923B (da) 1984-10-02
GB8321222D0 (en) 1983-09-07
FR2531433A1 (fr) 1984-02-10
NL8302776A (nl) 1984-03-01
AU563736B2 (en) 1987-07-23
IL69450A (en) 1986-10-31
GB2125041A (en) 1984-02-29
AT383125B (de) 1987-05-25
PT77168B (en) 1986-03-27

Similar Documents

Publication Publication Date Title
DE68906816T2 (de) Piperidin- und Piperazinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
US6379649B1 (en) Imidazo(1,2-a)pyridines as peripheral benzodiazepine receptor binding agents
CZ288944B6 (cs) Derivát 5H-thiazolo[3,2-a]pyrimidinu, způsob jeho přípravy, meziprodukt pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
EP0482939A1 (en) Isoquinolinone derivative
PT1354884E (pt) Composto de ciclopenta (d) pirazolo [1,5-a] piramida como antagonista de receptor de crf
NZ238141A (en) 1,2,3,4,4a,10b-hexahydro-6-(sulphonamidophenyl)benzo(c)(1,6)naphthyridine derivatives, preparation and pharmaceutical compositions thereof
HUT65947A (en) Imidazo-pyridine - derivatives with paf/h1 antagonist activity and pharmaceutical compositions containing them and process for the production thereof
CN113698388B (zh) 6-氧代-1,6-二氢吡啶类衍生物、其制备方法及其在医药上的应用
US3843663A (en) 1,8-naphthyridine compounds
JPS5948480A (ja) 麦角アルカロイド
RU2165420C2 (ru) 1,2,5-тиадиазольные производные индолилалкил-пиримидинил-пиперазинов и фармацевтическая композиция на их основе
JPH07505394A (ja) 橋渡しビスアリールカルビノール誘導体，組成物および使用法
CA2317515A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
AP1208A (en) 2-Aminopyridines containing fused ring substituents
JPS61100579A (ja) ピリジン誘導体
JPS61158980A (ja) ８α‐アシルアミノエルゴリン類、その製法および医薬組成物
DE69903627T2 (de) Tetrahydroisochinolinderivate als modulatoren von dopamin d3 rezeptoren
WO1996021662A1 (en) THE USE OF HETEROCYCLIC COMPOUNDS AS ANTIOXIDANTS, RADICAL SCAVENGERS, Fe2+ COMPLEXING AGENTS, TISSUE- AND/OR NEUROPROTECTANTS
JPH03294277A (ja) ピペリジン誘導体
JPS59184162A (ja) キノリン誘導体、その製造法及び該化合物を含有する、５―ヒドロキシトリプタミン桔抗質として使用する医薬組成物
PT99280B (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
JPH01242574A (ja) 含窒素縮合環を有するピペリジン及びピペラジン誘導体、その製造方法並びにそれを含む薬学的組成物
WO2021233427A1 (zh) 并环化合物及其制备方法、药物组合物和应用
EP0119541A1 (en) Substituted 4,10-dihydro-10-oxothieno-benzoxepins, a process for their preparation and their use as medicaments
JPH0495071A (ja) カルバミン酸誘導体